Anthracycline dose intensification in acute myeloid leukemia Academic Article uri icon

Overview

MeSH Major

  • Antibiotics, Antineoplastic
  • Antineoplastic Combined Chemotherapy Protocols
  • Daunorubicin
  • Leukemia, Myelomonocytic, Acute

abstract

  • In young adults with AML, intensifying induction therapy with a high daily dose of daunorubicin improved the rate of complete remission and the duration of overall survival, as compared with the standard dose. (ClinicalTrials.gov number, NCT00049517.)

publication date

  • September 24, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4480917

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa0904544

PubMed ID

  • 19776406

Additional Document Info

start page

  • 1249

end page

  • 59

volume

  • 361

number

  • 13